Kaloba

Dry extract of Pelargonium root, the active ingredient in Kaloba, is a herbal presented as a dry extract oral preparation for oral use. It is traditionally used to support respiratory health in adults.

GNH USA supplies Kaloba as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kaloba, containing dry extract of Pelargonium root, is used primarily for supportive care of upper respiratory conditions.

- Common Cold: may help alleviate symptoms such as sore throat, nasal congestion and cough. - Influenza: supports relief of flu‑related discomfort and promotes faster recovery. - Bronchitis: may assist in easing bronchial irritation and reducing cough frequency.

Kaloba is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Gastrointestinal upset: mild nausea or stomach discomfort. - Headache: transient mild headache. - Dizziness: occasional light‑headedness. - Taste alteration: temporary change in taste perception. - Mild skin irritation: occasional itching or redness at the oral mucosa.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling or difficulty breathing. - Anaphylaxis: rare but severe systemic allergic response. - Hepatic enzyme elevation: abnormal liver function tests. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hematologic changes: rare blood count abnormalities.

When considering Kaloba, several safety measures should be observed. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: use only if recommended by a clinician. - Children: safety not established; use under professional guidance. - Hepatic impairment: caution advised, monitor liver function. - Drug interactions: inform the prescriber of all concurrent medicines. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Kaloba may interact with other medicines; awareness of potential interactions is important.

Major Interactions (Avoid): - Anticoagulants: may increase bleeding risk. - Immunosuppressants: may reduce therapeutic efficacy.

Moderate Interactions (Monitor Closely): - Antihistamines: possible additive sedative effect. - CYP450 substrates: potential alteration of metabolism. - Other herbal supplements: additive pharmacologic actions. - Antidiabetic agents: may affect blood glucose control.